Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Click and bio-orthogonal chemistry take Nobel Prize 2022

NHS seeks digital solution for “treatment gap” in mental health

Bill aims to limit CMS’ “overreach” on Alzheimer’s drugs

Gulf War Illness: How can disease modelling aid the search for a cure?

As gonorrhoea threat grows, Intravacc gets $14m for vaccine hunt

Johnson&Johnson

nine for 2022 part 2

Digital/ Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Nine for 2022: innovation and opportunities in healthcare

mike.hammerton@pharmaphorum.com COVID-19, digital, digital health, IQVIA, Johnson&Johnson, R&D, rna, vaccine 0 Comment

In the second part of our examination of issues that will shape the course of 2022, we’ll update

X

Nine for 2022: innovation and opportunities in healthcare

https://pharmaphorum.com/digital/2022-innovation-opportunities-healthcare-digital/

J&J hopes to overturn $4.69bn compensation bill

News/ Oncology/ Patients

J&J hopes to overturn $4.69bn compensation bill

Piotr Wnuk Baby Powder, Johnson & Johnson, Johnson&Johnson, ovarian cancer 0 Comment

Johnson & Johnson lawyers are gearing up to appeal a court ruling, which rewarded billions to 22 women

X

J&J hopes to overturn $4.69bn compensation bill

https://pharmaphorum.com/news/jj-hopes-to-overturn-4-69bn-compensation-bill/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

GSK's Jemperli/TIM-3 immuno-oncology combo moves to ph3
AstraZeneca pays record 660% premium for gene editing company LogicBio
Roche gets FDA approval for HER2 breast cancer diagnostic
Translarna not approved by NICE for DMD on NHS
Novo Nordisk achieve headline results with icodec insulin

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com